NSE: CLEAN · 3 November 2026
- Clean Science and Technology has fallen 11.00% over 3 trading sessions; today's move is -0.57%.
- Clean Fino-Chem Limited, a wholly owned subsidiary of Clean Science and Technology Limited, successfully completed product trials for advanced grades of HALS products developed in collaboration with Geneus Chem AG. The trials met internal quality benchmarks and international regulatory standards, setting the stage for commercial launches expected in the second half of fiscal 2027. This milestone aligns with the company's broader strategic growth objectives and product diversification efforts.
- Trading volume was 1.58 times the 20-day average daily volume.
Clean Science and Technology share price: 11.00% decline over 3 trading sessions
Clean Science and Technology Ltd. (CLEAN) moved lower by 0.57% on Tuesday, closing at ₹658.80 after hovering between a day's high of ₹670.00 and a low of ₹655.00.
The broader market exhibited strong upward momentum as the Nifty advanced by 1.58%, whereas the Nifty Metal sector benchmark edged down slightly by 0.14%. Clean Science underperformed both the broader index and its immediate sectoral context, continuing a broader corrective phase that includes a 5-day return of -11.45% and a 20-day return of -17.63%.
Company disclosures provide ongoing context regarding the commercialization of its wholly owned subsidiary Clean Fino-Chem Limited (CFCL), which completed advanced HALS product trials in late October 2026 with commercial launches expected through the second half of fiscal 2027. While these developments reflect structural capacity expansion, today's negative price action appears largely aligned with continued near-term profit-taking and recent technical weakness following previous declines.
3.74 lakh shares traded by 3 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 2.36 lakh shares (1.58 times). The five-day average daily volume was 3.51 lakh shares. Separately, the NSE report for 3 November 2026 showed 1.84 lakh shares delivered, representing 49.05% of that day’s traded volume. The same report recorded 27,347 trades.
The stock declined by 0.57% amid elevated volume running at 1.58x its 20-day average. In the absence of a direct same-day catalyst, the downward drift reflects ongoing selling pressure and continuation of its recent corrective trend.
Latest Company Developments
Clean Fino-Chem Limited, a wholly owned subsidiary of Clean Science and Technology Limited, successfully completed product trials for advanced grades of HALS products developed in collaboration with Geneus Chem AG. The trials met internal quality benchmarks and international regulatory standards, setting the stage for commercial launches expected in the second half of fiscal 2027. This milestone aligns with the company's broader strategic growth objectives and product diversification efforts.
It marks a key operational step toward scaling the HALS segment, which is positioned as a primary growth vector following substantial capital expenditure.
The Board of Directors approved the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, during their meeting held on October 31, 2026. The financial updates highlighted progressive revenue growth supported by newer segments, alongside margin moderation attributed to raw material and operational cost pressures.
Quarterly earnings updates directly influence market valuation, revenue growth comparisons, and margin expectations.
The Maharashtra Goods and Services Tax Department concluded search and seizure proceedings initiated at the company's premises and its wholly owned subsidiary. The department determined a GST liability of ₹9.9 crore under the Reverse Charge Mechanism, which is fully eligible for input tax credit, alongside ₹2.0 crore in interest and non-creditable tax liabilities that represent the net financial impact.
It resolves a regulatory inquiry with a defined, manageable financial impact and confirms that business operations remained uninterrupted.
Further to our letter dated 17th October, 2026 and in compliance with . Saturday, 31st October, 2026, have approved the Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September, 2026.
Declared final dividend of Rs. 4/- (400 %) per Equity Share of Re.1/- each fully paid up for the Financial Year ended 31st March, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 10.94% on 30 September 2026. This compares with 12.00% on 30 June 2026, a change of -1.06 percentage points.
The filing reported 22 MF/UTI holders.
Historical Bulk / Block Deals
What to Watch Next
- Commercial launch progress and revenue contribution from the HALS product range in CFCL during the second half of fiscal 2027
- Execution of Performance Chemical 2 slated for commercialization in H2 FY27
- Sustained delivery volumes and cash-market participation relative to the 20-day average volume
- Margin trends and raw material cost pressures in upcoming quarterly performance updates
Other Dated Coverage
More Clean Science and Technology news and dated analysis →
Frequently Asked Questions
What is the latest Clean Science and Technology company news?
Clean Fino-Chem Limited, a wholly owned subsidiary of Clean Science and Technology Limited, successfully completed product trials for advanced grades of HALS products developed in collaboration with Geneus Chem AG. The trials met internal quality benchmarks and international regulatory standards, setting the stage for commercial launches expected in the second half of fiscal 2027. This milestone aligns with the company's broader strategic growth objectives and product diversification efforts.
How strong was Clean Science and Technology’s trading volume?
3.74 lakh shares traded, 1.58 times the 20-day average daily volume. The price and volume data are dated 3 November 2026 · 03:30 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.